| 臺大學術典藏 |
2019 |
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
|
Huang P.-M.; CHIH-HUNG HSU; Lin C.-C.; Chang Y.-L.; Hsieh M.-S.; Cheng J.C.-H.; Lee J.-M.; Lu S.-L.;Hsu F.-M.;Tsai C.-L.;Lee J.-M.;Huang P.-M.;Chih-Hung Hsu;Lin C.-C.;Chang Y.-L.;Hsieh M.-S.;Cheng J.C.-H.; Lu S.-L.; Hsu F.-M.; Tsai C.-L. |
| 臺大學術典藏 |
2019 |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Tzen K.-Y.; Cheng A.-L.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; PEI-MING HUANG; Hsu F.-M.; Yeh K.-H.; Lin C.-C.; Huang T.-C.; Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Pei-Ming Huang;Hsu F.-M.;Yeh K.-H.;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H. |
| 臺大學術典藏 |
2019 |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Yang J.C.-H.; Tsai T.-H.; Chen K.-Y.; Yu C.-J.; Shih J.-Y.; WEI-YU LIAO; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Wei-Yu Liao;Shih J.-Y.;Yu C.-J.;Chen K.-Y.;Tsai T.-H.;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S. |
| 臺大學術典藏 |
2019 |
Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study
|
Ma W.-L.;Lin C.-C.;Hsu F.-M.;Jang-Ming Lee;Chen J.-S.;Hsieh M.-S.;Chang Y.-L.;Chao Y.-T.;Chang C.-H.;Chih-Hsin Yang J.; Ma W.-L.; Lin C.-C.; Hsu F.-M.; JANG-MING LEE; Chen J.-S.; Hsieh M.-S.; Chang Y.-L.; Chao Y.-T.; Chang C.-H.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2019 |
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
|
Lee J.-M.; Cheng J.C.-H.; MIN-SHU HSIEH; Chang Y.-L.; Lin C.-C.; Hsu C.-H.; Huang P.-M.; Lu S.-L.;Hsu F.-M.;Tsai C.-L.;Lee J.-M.;Huang P.-M.;Hsu C.-H.;Lin C.-C.;Chang Y.-L.;Min-Shu Hsieh;Cheng J.C.-H.; Lu S.-L.; Hsu F.-M.; Tsai C.-L. |
| 臺大學術典藏 |
2019 |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Yang J.C.-H.; Tsai T.-H.; Chen K.-Y.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; CHONG-JEN YU; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Shih J.-Y.;Chong-Jen Yu;Chen K.-Y.;Tsai T.-H.;Yang J.C.-H. |
| 臺大學術典藏 |
2019 |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Yang J.C.-H.; Tsai T.-H.; Chen K.-Y.; Yu C.-J.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; JIN-YUAN SHIH; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Jin-Yuan Shih;Yu C.-J.;Chen K.-Y.;Tsai T.-H.;Yang J.C.-H. |
| 臺大學術典藏 |
2018-09-10T14:50:19Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen, M.-L. and Yan, B.-S. and Lu, W.-C. and Chen, M.-H. and Yu, S.-L. and Yang, P.-C. and Cheng, A.-L.; Chen, Mei-Ling;Yan, Bo-Shiun;Lu, Wan-Chih;Chen, Mei-Huei;Yu, Sung-Liang;Yang, Pan-Chyr
Cheng, Ann-Lii; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; Hsu, F.M.; SUNG-LIANG YU; Chen, Mei-Ling; Chen, Mei-Ling; Yan, Bo-Shiun; BO-SHIUN YAN; Hsu, F.M.; ANN-LII CHENG; Lu, Wan-Chih; Chen, Mei-Huei; Chen, Mei-Huei; Yu, Sung-Liang; Yang, Pan-Chyr
Cheng, Ann-Lii; 楊泮池 |
| 臺大學術典藏 |
2018-09-10T07:34:06Z |
A bipolar host material containing triphenylamine and diphenylphosphoryl- substituted fluorene units for highly efficient blue electrophosphorescence
|
Hsu, F.-M.; Chien, C.-H.; Shu, C.-F.; Lai, C.-H.; Hsieh, C.-C.; Wang, K.-W.; Chou, P.-T.; Hsu, F.-M.; Chien, C.-H.; Shu, C.-F.; Lai, C.-H.; Hsieh, C.-C.; Wang, K.-W.; Chou, P.-T.; PI-TAI CHOU |
| 臺大學術典藏 |
2018-09-10T07:34:03Z |
Multifunctional deep-blue emitter comprising an anthracene core and terminal triphenylphosphine oxide groups
|
Chien, C.-H.; Chen, C.-K.; Hsu, F.-M.; Shu, C.-F.; Chou, P.-T.; Lai, C.-H.; Chien, C.-H.; Chen, C.-K.; Hsu, F.-M.; Shu, C.-F.; Chou, P.-T.; Lai, C.-H.; PI-TAI CHOU |
| 臺大學術典藏 |
2018 |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C.;Fu-Ren Xiao;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; FU-REN XIAO; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2018 |
Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
|
Hsu C.-H.; CHIA-HSIEN CHENG; Lee J.-M.; Lin C.-C.; Hsu F.-M.; Huang P.-M.;Hsu F.-M.;Lin C.-C.;Hsu C.-H.;Chia-Hsien Cheng;Lee J.-M.; Huang P.-M. |
| 臺大學術典藏 |
2018 |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Hsu F.-M.;Yang P.-C;Cheng J.C.-H;Kuo S.-H;Chih-Hsin Yang;Yu C.-J;Liao W.-Y;Chen K.-Y;Tseng H.-M;Chen Y.-F;Ho C.-C;Shih J.-Y;Xiao F;Yang W.-C; Yang W.-C; Xiao F; Shih J.-Y; Ho C.-C; Chen Y.-F; Tseng H.-M; Chen K.-Y; Liao W.-Y; Yu C.-J; CHIH-HSIN YANG; Kuo S.-H; Cheng J.C.-H; Yang P.-C; Hsu F.-M. |
| 臺大學術典藏 |
2018 |
Response to Stephane Renaud et al.
|
Hsu F.-M.; CHAO-CHI HO; Yang W.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2018 |
Response to Stephane Renaud et al.
|
Yang W.-C.;Shih J.-Y.;Chao-Chi Ho;Hsu F.-M.; Yang W.-C.; Shih J.-Y.; CHAO-CHI HO; Hsu F.-M. |
| 臺大學術典藏 |
2018 |
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
|
Tzen K.-Y.; Cheng A.-L.; Chen P.-J.; Cheng J.C.-H.; Yang P.-S.; RUOH-FANG YEN; Liu W.-L.; Hsu F.-M.; Tsai C.-L. |
| 國立臺灣大學 |
2016 |
M1a Nodal Involvement and Induction Taxane-Based Chemotherapy Before Neoadjuvant Chemoradiation Therapy Are Associated With Survival Outcomes in Pathological Complete Responder After Trimodality Treatment for Esophageal Squamous Cell Carcinoma
|
Lu, S. L.; Hsu, F. M.; Tsai, C. L.; Lee, J. M.; Huang, P. M.; Hsu, C. H.; Lin, C. C.; Chang, Y. L.; Hsieh, M. S.; Cheng, J. C. H.; 林家齊; 張逸良; 成佳憲; 徐志宏; 謝明書; 李章銘; 黃培銘; 蔡巧琳; 許峰銘 |
| 國立臺灣大學 |
2016 |
Preclinical Study on Radiosensitization by Combining a Novel Drug Lipotecan With Radiation Therapy in Hepatocellular Carcinoma
|
Cheng, J. C. H.; Liu, W. L.; Tsai, C. L.; Hsu, F. M.; 成佳憲; 蔡巧琳; 許峰銘 |
| 臺大學術典藏 |
2016 |
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
|
Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; CHIA-HSIEN CHENG; Hsu F.-M.; Lu S.-L.; Lu S.-L.;Hsu F.-M.;Chen K.-Y.;Ho C.-C.;Yang J.C.-H.;Chia-Hsien Cheng |
| 臺大學術典藏 |
2016 |
Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
|
Cheng J.C.-H.;Chih-Hsin Yang;Ho C.-C;Chen K.-Y;Hsu F.-M;Lu S.-L; Lu S.-L; Hsu F.-M; Chen K.-Y; Ho C.-C; CHIH-HSIN YANG; Cheng J.C.-H. |
| 國立臺灣大學 |
2015 |
EGFR Mutation Status Is Associated With Better Radiographic Response and Predicts Favorable Outcomes in Non-Small Cell Lung Cancer Patients With Brain Metastases Treated by Stereotactic Radiosurgery
|
Yang, W. C.; Xiao, F. R.; Shih, J. Y.; Ho, C. C.; Chen, Y. F.; Tseng, H. M.; Chen, K. Y.; Liao, W. Y.; Yu, C. J.; Yang, J. C. H.; Kuo, S. H.; Cheng, J. C. H.; Yang, P. C.; Hsu, F. M.; 曾漢民; 陳雅芳; 楊泮池; 廖唯昱; 郭頌鑫; 陳冠宇; 余忠仁; 成佳憲; 何肇基; 蕭輔仁; 施金元; 許?銘 |
| 臺大學術典藏 |
2015 |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; CHIA-HSIEN CHENG; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.; Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Chia-Hsien Cheng;Wang H.-P.;Yeh K.-H.;Cheng A.-L.;Hsu C.-H. |
| 臺大學術典藏 |
2015 |
Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy
|
Chia-Hsien Cheng J.; Chang D.T.; CHIH-HUNG HSU; Koong A.C.; Lee J.-M.; Huang P.-M.; Wu J.-K.; Tsai C.-L.; Lu S.-L.; Hsu F.-M.; Lu S.-L.;Hsu F.-M.;Tsai C.-L.;Wu J.-K.;Lee J.-M.;Huang P.-M.;Chih-Hung Hsu;Koong A.C.;Chang D.T.;Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2015 |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu C.-H.; Guo J.-C.; Huang T.-C.; Lin C.-C.; MIN-SHU HSIEH; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2015 |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang C.-C.;Chia-Hsien Cheng;Tsai C.-L.;Lee J.-M.;Huang P.-M.;Lin C.-C.;Hsu C.-H.;Hsieh M.-S.;Chang Y.-L.;Hsu F.-M.; Wang C.-C.; CHIA-HSIEN CHENG; Tsai C.-L.; Lee J.-M.; Huang P.-M.; Lin C.-C.; Hsu C.-H.; Hsieh M.-S.; Chang Y.-L.; Hsu F.-M. |
